🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/05/2002 | 66,10 | 67,56 | 64,27 | 67,41 | +1,75% | 4,98% | 87.551 |
| 29/05/2002 | 67,34 | 67,34 | 65,13 | 66,25 | -1,67% | 3,28% | 86.001 |
| 28/05/2002 | 63,82 | 67,37 | 63,82 | 67,37 | +5,51% | 5,57% | 64.441 |
| 24/05/2002 | 67,34 | 67,37 | 62,84 | 63,86 | -5,38% | 6,73% | 143.068 |
| 23/05/2002 | 66,33 | 67,49 | 65,50 | 67,49 | +0,67% | 2,99% | 91.424 |
| 22/05/2002 | 67,15 | 67,15 | 63,82 | 67,04 | -0,50% | 4,96% | 115.496 |
| 21/05/2002 | 67,52 | 69,25 | 66,55 | 67,37 | +0,00% | 3,99% | 83.650 |
| 20/05/2002 | 71,87 | 71,87 | 67,19 | 67,37 | -4,66% | 6,51% | 168.048 |
| 17/05/2002 | 64,04 | 70,85 | 63,82 | 70,67 | +11,39% | 10,99% | 304.036 |
| 16/05/2002 | 61,76 | 63,78 | 61,76 | 63,44 | +1,56% | 3,27% | 142.400 |
| 15/05/2002 | 62,17 | 64,75 | 60,75 | 62,47 | +1,52% | 6,44% | 179.750 |
| 14/05/2002 | 56,74 | 61,83 | 56,67 | 61,53 | +8,95% | 9,10% | 77.879 |
| 13/05/2002 | 56,56 | 58,58 | 56,14 | 56,48 | -0,40% | 4,30% | 74.566 |
| 10/05/2002 | 58,28 | 58,76 | 55,96 | 56,71 | -2,88% | 4,82% | 131.339 |
| 09/05/2002 | 59,14 | 59,36 | 58,20 | 58,39 | -1,52% | 1,96% | 99.813 |
| 08/05/2002 | 57,16 | 60,90 | 57,12 | 59,29 | +5,95% | 6,61% | 114.882 |
| 07/05/2002 | 56,18 | 58,65 | 55,40 | 55,96 | -0,40% | 5,80% | 243.282 |
| 06/05/2002 | 59,18 | 60,22 | 55,77 | 56,18 | -7,12% | 7,53% | 240.450 |
| 03/05/2002 | 58,50 | 60,79 | 57,01 | 60,49 | +0,69% | 6,46% | 233.370 |
| 02/05/2002 | 59,59 | 61,42 | 58,76 | 60,07 | +1,52% | 4,46% | 66.551 |
| 01/05/2002 | 59,10 | 62,21 | 58,35 | 59,18 | +1,54% | 6,52% | 98.184 |
| 30/04/2002 | 59,51 | 60,86 | 57,98 | 58,28 | -0,51% | 4,84% | 223.779 |
| 29/04/2002 | 57,60 | 59,89 | 57,01 | 58,58 | +1,62% | 5,00% | 239.194 |
| 26/04/2002 | 61,98 | 62,32 | 55,25 | 57,64 | -7,56% | 11,41% | 361.450 |
| 25/04/2002 | 64,94 | 65,28 | 61,76 | 62,36 | -4,53% | 5,42% | 206.867 |
| 24/04/2002 | 65,50 | 66,36 | 64,08 | 65,32 | -0,17% | 3,49% | 108.336 |
| 23/04/2002 | 68,38 | 68,68 | 65,32 | 65,43 | -4,84% | 4,93% | 164.708 |
| 22/04/2002 | 69,81 | 70,52 | 67,82 | 68,76 | -1,18% | 3,86% | 87.096 |
| 19/04/2002 | 67,94 | 69,99 | 67,90 | 69,58 | +0,65% | 3,09% | 104.756 |
| 18/04/2002 | 68,87 | 69,43 | 67,49 | 69,13 | -0,22% | 2,83% | 103.206 |